Speaker Biography

Vasyl Kishchuk

Vinnytsia Regional Clinical Hospital, Ukraine

Title: Results of an international, randomized clinical trial with a homeopathic medication in patients with recurrent tonsillitis

Vasyl Kishchuk
Biography:

Vasyl Kishchuk is awarded the title of Professor of the Department of Otorhinolaryngology at Vinnitsa National Medical University n.a. M. Pirogov. He is a highly qualified specialist who conducts up to 800 surgical procedures per year, advises about 5000 patients at various hospitals in Vinnitsa and Vinnitsa region. Scientific work of the department under the direction of professor Kishchuk V. Is dedicated to the problems of chronic tonsillitis, scleroma, endoscopic microsurgery, aesthetic surgery, pathology of the middle ear, nose and white-faced cavities, and improving of the treatment of patients with frontal-basal trauma of the skull. He is also the author and co-author of scientific publications, including textbooks for otolaryngology for students and interns, has 19 innovative proposals, 9 inventions. He constantly introduces new methods of surgical interventions on ENT organs. Vasyl as a talented teacher, doctor and scientist, enjoys a well-deserved authority among the staff of the department, university, students, doctors of Ukraine.

 

Abstract:

Background and aims: In the light of discussions regarding possible therapies of patients affected by a moderate recurrent tonsillitis (RT), for whom recent clinical guidelines recommend a watchful waiting period, the current clinical trial was performed. It assessed the effectiveness and safety of the homeopathic medicinal product SilAtro-5-90 in patients with moderate RT. The open-label randomized clinical trial was conducted in Germany, Spain and Ukraine in patients aged 6-60 years with moderate RT. The combined treatment of SilAtro-5-90 (Atropinum sulfuricum D5, Hepar sulfuris D3, Kalium bichromicum D4, Silicea D2, Mercurius bijodatus D8) and symptomatic medication (test group) was compared to symptomatic medication alone (control group). SilAtro-5-90 was given during 3 treatment periods of 8 weeks each. Endpoints were the mean period between consecutive acute throat infections (ATI) within 1 year (analysed via repeated events analysis), the number of days the patients were suffering from RT symptoms as well as the incidence of adverse events (AEs). Trial results indicate that SilAtro-5-90 may be a well-tolerated and effective therapeutic option in the treatment of moderate.

 

Lomaeva Yuliya Vladimirovna

Viterra multidisciplinary clinic, Russia

Title: Results of an international, randomized clinical trial with a homeopathic medication in patients with recurrent tonsillitis

Lomaeva Yuliya Vladimirovna
Biography:

Dr. Iuliia Lomaeva works in the field of Pediatric otorhinolaryngology, phoniatrics. In everyday work, she faces a huge number of children suffering from hypertrophy of adenoids. She pays great attention to physiotherapy. She is looking for effective ways of conservative treatment of hypertrophy of adenoids.

 

Abstract:

Adenoid hypertrophy (AH) refers to the most common pathology of Pediatric otorhinolaryngology. The lymphatic pharyngeal ring plays a leading role in creating the immune barrier of the upper respiratory tract. In this regard, the conservative methods of therapy that do not require surgical intervention and ensure the preservation of the immune protection are more relevant. The study included 53 patients with AH: 32 boys and 21 girls at 7.1 ± 2.5 years old. Patients were divided into 2 groups: the 1st (control) - 28 patients with standard treatment of AH and the 2nd (main) - 25 patients with standard treatment and physiotherapy: intranasal, oral laser irradiation and ultrasonic cavitation treatment (10 procedures). Additionally, all participants in the study were examined by ENT, including endoscopy of the nasal cavity and nasopharynx; an objective assessment of the state of the auditory analyser (acoustic impedance measurement). The analysis of the conducted studies revealed that in the main group of test subjects after the course of treatment, nasal breathing was restored in 84% of children, whereas in the control group, nasal breathing was restored in 57%. There was also a significant change in the degree of hypertrophy in the main group compared with the control group. It was revealed that after the course of treatment in the main group in children AH grade 2 decreased to grade 1 in 67% of the cases and in children with initial hypertrophy grade 3 - AH decreased to the grade 2 in 71% of the cases. Thus, the additional use of physiotherapy in the conservative treatment of AH is more effective in comparison with standard therapy